Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Marrow Neoplasms × SCIO-469 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Hematologic Diseases 1 Bone Marrow Neoplasms 1 Bone Marrow Diseases 1

Interventions

Lenalidomide 2 Dexamethasone 2 Bortezomib 2 darinaparsin 1 carfilzomib 1 belinostat 1 SCIO-469 1 Low-Level Light Therapy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00113893 2013-11-07

SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.

Scios, Inc.

Phase 2 Completed

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Bone Marrow Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡